Literature DB >> 25532720

A multicenter prospective study on the prevalence of Helicobacter pylori-negative and nonsteroidal anti-inflammatory drugs-negative idiopathic peptic ulcers in Japan.

Takeshi Kanno1, Katsunori Iijima, Yasuhiko Abe, Makoto Yagi, Sho Asonuma, Motoki Ohyauchi, Hirotaka Ito, Tomoyuki Koike, Tooru Shimosegawa.   

Abstract

BACKGROUND AND AIM: The prevalence of Helicobacter pylori-negative and nonsteroidal anti-inflammatory drug-negative peptic ulcers, commonly known as idiopathic peptic ulcers (IPUs), has been reported to be very low (0.9-2.6%) in Japan based on data from the 1990s. However, recent trends have yet to be been reported. Herein, we present a multicenter prospective analysis between 2012 and 2013 investigating current trends in the prevalence and characteristics of IPUs in Japan.
METHODS: Clinical data of all peptic ulcer subjects detected via endoscopy at four participating hospitals were prospectively collected between April 2012 and March 2013. Enrolled subjects were classified according to H. pylori infection status and intake of nonsteroidal anti-inflammatory drugs. Multiple logistic regression analyses were used to determine the risk factors for IPUs.
RESULTS: Of 382 enrolled patients with peptic ulcers, 46 (12%) were judged to have IPUs. Compared with those with simple H. pylori-positive ulcers, patients with IPUs were significantly older (P < 0.02) and more often had underlying comorbidities such as hypertension (P < 0.02) and hyperlipidemia (P < 0.05). Multivariate regression analysis indicated that the presence of multiple underlying diseases was the only significant risk factor for IPUs, with an odds ratio of 3.8 (95% confidence interval, 1.3-11.1).
CONCLUSIONS: This study revealed that the prevalence of IPUs in patients with peptic ulcers in Japan is 12%, much higher than previously reported. Presence of multiple underlying comorbid diseases, rather than aging itself, is an important risk factor for IPUs.
© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Helicobacter pylori; idiopathic peptic ulcers; nonsteroidal anti-inflammatory drug; risk factors

Mesh:

Substances:

Year:  2015        PMID: 25532720     DOI: 10.1111/jgh.12876

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

1.  Is the new potent acid-inhibitory drug vonoprazan effective for healing idiopathic peptic ulcers? A multicenter observational study in Akita Prefecture, Japan.

Authors:  Kae Sugawara; Shigeto Koizumi; Yohei Horikawa; Nobuya Mimori; Tsuyotoshi Tsuji; Hajime Ishii; Shusei Fujimori; Kengo Onochi; Hiroyuki Watanabe; Katsunori Iijima
Journal:  J Gastroenterol       Date:  2019-04-29       Impact factor: 7.527

Review 2.  Geographic differences in low-dose aspirin-associated gastroduodenal mucosal injury.

Authors:  Katsunori Iijima; Tooru Shimosegawa
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

3.  An extended 36-week oral esomeprazole improved long-term recurrent peptic ulcer bleeding in patients at high risk of rebleeding.

Authors:  Hsueh-Chien Chiang; Er-Hsiang Yang; Huang-Ming Hu; Wei-Ying Chen; Wei-Lun Chang; Chung-Tai Wu; Deng-Chyang Wu; Bor-Shyang Sheu; Hsiu-Chi Cheng
Journal:  BMC Gastroenterol       Date:  2022-10-21       Impact factor: 2.847

4.  Clinical characteristics of Helicobacter pylori-negative drug-negative peptic ulcer bleeding.

Authors:  Woo Chul Chung; Eun Jung Jeon; Dae Bum Kim; Hea Jung Sung; Yeon-Ji Kim; Eun Sun Lim; Min-Ah Kim; Jung Hwan Oh
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

5.  Refractory gastric antral ulcers without Helicobacter pylori infection and non-steroidal anti-inflammatory drugs.

Authors:  Hirotada Nishie; Hiromi Kataoka; Hiroyuki Kato; Taketo Suzuki; Hiroshi Ichikawa; Yu Nojiri; Mika Kitagawa; Yusuke Inagaki; Hiroyasu Iwasaki; Mamoru Tanaka; Takahito Katano; Yasuyuki Okamoto; Keiji Ozeki; Tsutomu Mizoshita; Takaya Shimura; Eiji Kubota; Satoshi Tanida; Takashi Joh
Journal:  Clin J Gastroenterol       Date:  2018-02-16

Review 6.  Recent advances in the management of peptic ulcer bleeding.

Authors:  Ian Beales
Journal:  F1000Res       Date:  2017-09-27

7.  Clinical implications of pre-existing adenoma in endoscopically resected early gastric cancers.

Authors:  Ji Min Choi; Sang Gyun Kim; Jung Kim; Seung Jun Han; Jae Yong Park; Sooyeon Oh; Jong Pil Im; Joo Sung Kim; Woo Ho Kim; Hyun Chae Jung
Journal:  PLoS One       Date:  2017-05-25       Impact factor: 3.240

8.  A Rare Case of Gastric Ulcer Penetrating the Pancreas that was Successfully Managed by Conservative Therapy.

Authors:  Narihiro Shibukawa; Shohei Ouchi; Shuji Wakamatsu; Yuhei Wakahara; Nobuyuki Tatsumi; Akira Kaneko
Journal:  Intern Med       Date:  2017-08-10       Impact factor: 1.271

9.  Effects of alcohol consumption, cigarette smoking, and betel quid chewing on upper digestive diseases: a large cross-sectional study and meta-analysis.

Authors:  Yun-Shiuan Chuang; Meng-Chieh Wu; Fang-Jung Yu; Yao-Kuang Wang; Chien-Yu Lu; Deng-Chyang Wu; Chie-Tong Kuo; Ming-Tsang Wu; I-Chen Wu
Journal:  Oncotarget       Date:  2017-09-11

10.  Eosinophilic Gastroenteritis-associated Duodenal Ulcer Successfully Treated with Crushed Budesonide.

Authors:  Kimitoshi Kubo; Noriko Kimura; Katsuhiro Mabe; Soichiro Matsuda; Momoko Tsuda; Mototsugu Kato
Journal:  Intern Med       Date:  2020-06-15       Impact factor: 1.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.